Table 6.
Group/Organ a | Non-GM (g/kg) | GM-1 (g/kg) | GM-2 (g/kg) | |||
---|---|---|---|---|---|---|
1 | 5 | 1 | 5 | 1 | 5 | |
Male | ||||||
Adrenal (%) | 0.08 ± 0.02 | 0.08 ± 0.01 | 0.08 ± 0.01 | 0.10 ± 0.02 * | 0.08 ± 0.02 | 0.11 ± 0.02 * |
Brain (%) | 0.4 ± 0.0 | 0.4 ± 0.0 | 0.4 ± 0.0 | 0.4 ± 0.0 | 0.4 ± 0.0 | 0.4 ± 0.0 |
Heart (%) | 0.3 ± 0.0 | 0.3 ± 0.0 | 0.3 ± 0.0 | 0.3 ± 0.0 | 0.3 ± 0.0 | 0.3 ± 0.0 |
Liver (%) | 2.4 ± 0.3 | 2.2 ± 0.2 | 2.4 ± 0.1 | 2.4 ± 0.2 | 2.3 ± 0.2 | 2.2 ± 0.2 |
Kidney (%) | 0.6 ± 0.0 | 0.7 ± 0.1 | 0.6 ± 0.0 | 0.6 ± 0.1 | 0.6 ± 0.0 | 0.6 ± 0.1 |
Spleen (%) | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 |
Thymus (%) | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 |
Testes (%) | 0.6 ± 0.0 | 0.7 ± 0.1 | 0.6 ± 0.0 | 0.7 ± 0.1 | 0.6 ± 0.1 | 0.7 ± 0.1 |
Female | ||||||
Adrenal (%) | 0.18 ± 0.01 | 0.2 ± 0.05 | 0.18 ± 0.06 | 0.18 ± 0.06 | 0.20 ± 0.05 | 0.19 ± 0.05 |
Brain (%) | 0.7 ± 0.1 | 0.7 ± 0.1 | 0.7 ± 0.1 | 0.7 ± 0.1 | 0.7 ± 0.1 | 0.6 ± 0.1 |
Heart (%) | 0.3 ± 0.0 | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.3 ± 0.0 | 0.3 ± 0.0 |
Liver (%) | 2.4 ± 0.3 | 2.3 ± 0.4 | 2.3 ± 0.4 | 2.4 ± 0.5 | 2.4 ± 0.3 | 2.2 ± 0.4 |
Kidney (%) | 0.6 ± 0.0 | 0.7 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.7 ± 0.1 | 0.6 ± 0.1 |
Spleen (%) | 0.2 ± 0.0 | 0.1 ± 0.0 | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.2 ± 0.1 |
Thymus (%) | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 |
Ovary (%) | 0.02 ± 0.0 | 0.03 ± 0.0 | 0.02 ± 0.0 | 0.02 ± 0.0 | 0.03 ± 0.0 | 0.02 ± 0.0 |
Data are expressed as the mean ± SD (n = 9–10). a Relative organ weight (%) = (organ weight (g)/final body weight (g)) × 100. * Significant difference between the same dosage of non-GM and GM groups at p < 0.05.